Seeking Alpha

ScriptVolume

View as an RSS Feed
View ScriptVolume's Articles BY TICKER:
  • Large, Diverse Pipelines At Small Biotech Companies
    on Mar. 13, 2012 GSK, ISIS, LGND 5 Comments
  • Generic Competition: The $100 Billion Biologics Arena
    on Mar. 6, 2012 HSP, MNTA, MRK 3 Comments
  • Invest Alongside Pfizer And Stack The Odds In Your Favor
    on Feb. 28, 2012 EBS, LPTN, PFE 1 Comment
  • Small Biotech Companies With Big Pipelines
    on Feb. 23, 2012 BIIB, DYAX, HALO 8 Comments
  • Theravance: A $1.5 Billion Company With An $8 Billion Product
    on Feb. 22, 2012 AZN, GSK, PFE 5 Comments
  • Selling Drugs: Small Biotech Stocks With Strong Sales Growth
    on Feb. 13, 2012 DNDN, JAZZ, PFE 5 Comments
  • Big, Robust Pipelines At Small Biotech Companies
    on Feb. 7, 2012 ASTX, ANIP, EXEL 5 Comments
  • Small Pharma With Big Compounds: Final Dance With The FDA
    on Feb. 6, 2012 AZN, GSK, LLY 11 Comments
  • Small Biotech Companies With Big, Promising Pipelines
    on Jan. 31, 2012 IMMU, JAZZ, PFE 11 Comments
  • Trius Therapeutics: Weakness Presents Opportunity
    on Jan. 27, 2012 ABT, BAYZF, BMY 2 Comments
  • Seattle Genetics: Boxed Warning Is A Non-Event
    on Jan. 22, 2012 SGEN, BMY, GSK 8 Comments
  • Transcept's Intermezzo: A Blockbuster In The Making
    on Jan. 3, 2012 SNY, PFE, TSPT 16 Comments
  • Cadence Pharmaceuticals: Good For Patients, Bad For Investors
    on Dec. 26, 2011 MNK 2 Comments
  • Bulls And Bears Alive For Synavive At Zalicus Incorporated
    on Dec. 21, 2011 PFE, MRK, GSK 2 Comments
  • The Sun May Not Rise At Horizon Pharma For Duexis
    on Dec. 18, 2011 HZNP, JNJ, PFE 3 Comments
  • Catalyst Pharmaceutical May Need More Stimulus
    on Dec. 12, 2011 RBGPY, FRX, CPRX Comment!
  • Nupathe's Zelrix Going Down A Path With Multiple Headwinds
    on Dec. 9, 2011 PFE, MRK, AZN Comment!
  • Lpath Is Many Years Ahead Of The Competition
    on Dec. 7, 2011 LPTN Comment!